Related Experiment Video
Updated: Feb 28, 2026

Human Dupuytren's Ex Vivo Culture for the Study of Myofibroblasts and Extracellular Matrix Interactions
Published on: April 18, 2015
Complications Following Collagenase Treatment for Dupuytren Contracture
Jennifer Wozniczka1, Clifford Canepa2, Adam Mirarchi1
11 Oregon Health & Science University, Portland, USA.
Background:
Collagenase Clostridium histolyticum (CCH) injection and manipulation is a relatively new method for treating Dupuytren contracture that is growing in popularity. Although side effects such as swelling and ecchymosis are common, they are typically mild and self-limited. Major complications are rare but have included flexor tendon rupture and complex regional pain syndrome.
Methods:
This study describes a case report of 2 patients seen at our institution.
Results:
Here, we report 2 patients seen at our institution each with different, yet serious complications after CCH injection and manipulation. One patient had extensive skin loss and chose amputation over reconstruction. The other patient had loss of perfusion and required finger amputation.
Conclusions:
Although it is unclear how directly the administration of CCH is connected to the observed complications, physicians should recognize the potential for serious rare complications in any treatment of Dupuytren contracture.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Aneurysm III: Interprofessional Care

